TRDA
Entrada Therapeutics, Inc. · Healthcare
COO Nathan J Dowden sold $113K of Entrada Therapeutics, Inc.
Sold$113,426
$18.66Price
6,080Shares
−10%Stake
What TRDA did after the filing
- The stock from Tue, Oct 25 open, $20.83
- −14.9%
- S&P 500, same days
- +3.8%
Measured over 30 trading days, to the Dec 7 close.
Traded Thu, Oct 20. Filed Mon, Oct 24, 5:13 PM ET, after the close. Returns use the Oct 25 open and the Dec 7 close. Not investment advice.